Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer

Danka Sinikovic Zebic*, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, Michael Friedlander, Val Gebski, Alain Lortholary, Florence Joly, Annette Hasenburg, Mansoor Mirza, Ursula Denison, Sabrina Chiara Cecere, Annamaria Ferrero, Eric Pujade-Lauraine, Chee Khoon Lee

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences